Incyte Plans Phase 3 Trial of INCB161734 for Colorectal Cancer in First Half of 2027
Incyte plans a Phase 3 study of INCB161734 for colorectal cancer in the first half of 2027.
Incyte plans a Phase 3 study of INCB161734 for colorectal cancer in the first half of 2027.